Sort
48,018 grants matching “immunotherapy”
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,292,577Mark Larche · Mcmaster University · U19 · FY2014 · AI
timsTOF fleX with MALDI-2 for Advanced Mass Spectrometry Imaging
$1,291,625Kristine Glunde · Johns Hopkins University · S10 · FY2021 · OD
Dendritic cells heterogeneity and function
$1,290,048Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
SPORE in Skin Cancer
$1,289,947Wistar Institute · P50 · FY2002 · CA
Vectored HIV Immunotherapy via in vivo B cell editing
$1,289,517David T Curiel · Washington University · R01 · FY2024 · AI
Lymph nodes at the crossroads of allo immunity and regulation
$1,289,295Reza Abdi · Brigham And Women'S Hospital · P01 · FY2020 · AI
Acquired Resistance to Therapy and Iron (ARTI) Center
$1,289,134Boyi Gan · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Medical Oncology Service Clinical Core
$1,288,963James L. Gulley · Division Of Basic Sciences - Nci · ZID · FY2019 · CA
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,288,316Children'S Memorial Hospital (Chicago) · U01 · FY2000 · AI
Role of co-receptor modified cells in HIV infection
$1,287,047Carl H. June · University Of Pennsylvania · R01 · FY2012 · AI
Novel approaches to cancer therapy
$1,286,288University Of Pennsylvania · P01 · FY2002 · CA
Identification of immune evasion mechanisms in the osteosarcoma microenvironment
$1,285,628Troy McEachron · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Immunobiology and Immunotherapy of Pediatric Tumors
$1,284,838Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Functional Biology Of T Cells
$1,284,582Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Rational Approaches to Melanoma Therapy
$1,284,372Jessie Villanueva · Wistar Institute · U54 · FY2025 · CA
Immunotherapy targeting the HPA axis in Alzheimer's disease
$1,283,668Todd E. Golde · Emory University · RF1 · FY2019 · AG
SYSTEMIC CHARACTERIZATION OF KIDNEY CANCER TUMOR SUPPRESSORS IN MODULATING METASTASIS AND RESPONSE TO IMMUNOTHERAPY.
$1,283,229Sloan-Kettering Institute For Cancer Research · · FY2021 · Defense Health Agency
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,283,220Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Ann Arbor regional CCOP
$1,282,877Saint Joseph Mercy Health System · U10 · FY2003 · CA
Novel approaches to cancer therapy
$1,282,639University Of Pennsylvania · P01 · FY2003 · CA
Center for Multiparametric Imaging of Tumor Immune Microenvironments
$1,282,583Paolo Provenzano · University Of Minnesota · U54 · FY2024 · CA
Cancer Biomaterials Engineering
$1,281,899Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The cBioPortal for Cancer Genomics
$1,281,528Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2021 · CA
The cBioPortal for Cancer Genomics
$1,281,528Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2020 · CA
A SIMPLE AND COST EFFECTIVE CERVICAL CANCER VACCINE
$1,280,858Frank Bedu-Addo · Pds Biotechnology Corporation · N44 · FY2009 · CA